The impact of disease recurrence on graft survival following liver transplantation: A single centre experience

Transplant International

Volumn 21, Issue 5, 2008, Pages 459-465

  Rowe, Ian A ^a   Webb, Kerry ^a   Gunson, Bridget K ^a   Mehta, Naimish ^a   Haque, Sayeed ^b   Neuberger, James ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Autoimmune liver disease; Hepatitis C virus; Liver transplant; Recurrent disease

Indexed keywords

ARTICLE; AUTOIMMUNE HEPATITIS; CONFIDENCE INTERVAL; GRAFT FAILURE; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; NONALCOHOLIC FATTY LIVER; OUTCOME ASSESSMENT; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RECURRENT DISEASE; RISK ASSESSMENT;

ADULT; GRAFT SURVIVAL; HEPATITIS C; HEPATITIS, AUTOIMMUNE; HUMANS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 41749097631     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/j.1432-2277.2007.00628.x     Document Type: Article

References (28)

1. Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol 2006 5 : 77.
2. Burra P, Mioni D, Cecchetto A, et al. Histological features after liver transplantation in alcoholic cirrhosis. J Hepatol 2001 34 : 716.
3. Tang H, Bolton R, Hubscher S, Gunson B, Neuberger J. Patterns of alcohol consumption after liver transplantation. Gut 1998 43 : 140.
4. Ong J, Younossi ZM, Reddy V, et al. Cryptogenic cirrhosis and post-transplantation non-alcoholic fatty liver disease. Liver Transpl 2001 7 : 797.
5. Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med 1996 334 : 815.
6. Feray C, Caccamo L, Alexander GJ, et al. European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group. Gastroenterology 1999 117 : 619.
7. Wali MH, Heydtmann M, Harrison RF, Gunson B, Mutimer D. Outcome of liver transplantation for patients infected by hepatitis C, including those infected by genotype 4. Liver Transpl 2003 9 : 796.
8. Charlton M, Kasparova P, Weston S, et al. Frequency of non-alcoholic steatohepatitis as a cause of advanced liver disease. Liver Transpl 2001 7 : 608.
9. Bernal W, Wendon J, Rela M, et al. Use and outcome of liver transplantation in acetaminophen-induced acute liver failure. Hepatology 1998 27 : 1050.
10. Neuberger J, Gunson B, Hubscher S, Nightingale P. Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2004 10 : 488.
11. Vera A, Moledina S, Gunson B, et al. Risk factors for recurrence of primary sclerosing cholangitis of liver allograft. Lancet 2002 360 : 1943.
12. Graziadei IW. Recurrence of primary sclerosing cholangitis after liver transplantation. Liver Transpl 2002 8 : 575.
13. Milkiewicz P, Hubscher SG, Skiba G, Hathaway M, Elias E. Recurrence of autoimmune hepatitis after liver transplantation. Transplantation 1999 68 : 253.
14. Gautam M, Cheruvattath R, Balan V. Recurrence of autoimmune liver disease after liver transplantation: a systematic review. Liver Transpl 2006 12 : 1813.
15. Belle S, Beringer K, Detre K. Liver transplantation for alcoholic liver disease in the United States. Liver Transpl Surg 1997 3 : 212.
16. Neuberger J, Tang H. Relapse after transplantation: european studies. Liver Transpl Surg 1997 3 : 275.
17. Berlakovich GA. Wasting your organ with your lifestyle and receiving a new one? Ann Transplant 2005 10 : 38.
18. Keeffe E.B. Assessment of the alcoholic patient for liver transplantation: comorbidity, outcome and recidivism. Liver Transpl and Surg 1996 2 (Suppl. 1 12.
19. Perry I, Neuberger J. Immunosuppression: towards a logical approach in liver transplantation. Clin Exp Immunol 2005 139 : 2.
20. Poonawala A, Nair SP, Thuluvath PJ. Prevalence of obesity and diabetes in patients with cryptogenic cirrhosis: a case-control study. Hepatology 2000 32 : 689.
21. Markowitz JS, Martin P, Conrad AJ, et al. Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin. Hepatology 1998 28 : 585.
22. Marzano A, Salizzoni M, Debemardi-Venon W, et al. Prevention of hepatits B recurrence after liver transplantation in cirrhostic patients treated with lamivudine and passive immunoprophylaxis. J Hepatol 2001 34 : 903.
23. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996 334 : 693.
24. Bizollon T, Ahmed SN, Radenne S, et al. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis c virus recurrence. Gut 2003 52 : 283.
25. Charatcharoenwitthaya P, Pimentel S, Talwalkar JA, et al. Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl 2007 13 : 1236.
26. Georgiou G, Webb K, Griggs K, Copello A, Neuberger J, Day E. First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation. Liver Transpl 2003 9 : 772.
27. Mackie J, Groves K, Hoyle A, et al. Orthotopic liver transplantation for alcoholic liver disease: a retrospective analysis of survival, recidivism, and risk factors predisposing to recidivism. Liver Transpl 2001 7 : 418.
28. Pageaux G-P, Bismuth M, Perney P, et al. Alcohol relapse after liver transplantation for alcoholic liver disease: does it matter? J Hepatol 2003 38 : 629.